SCHEMBL30102471

SCHEMBL30102471

CN1CCN(c2ccc3ccc(N)nc3c2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
GAA P10253 3/20 0.55
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
GLA P06280 1/20 0.55
HTR3A P46098 3/20 0.54
MAPT P10636 4/20 0.53
PTK2B Q14289 2/20 0.53
MAPK1 P28482 1/20 0.53
HTT P42858 1/20 0.53
RECQL P46063 1/20 0.53
ADRA2C P18825 2/20 0.51
ALDH1A1 P00352 2/20 0.51
GFER P55789 1/20 0.51
ESR2 Q92731 1/20 0.51
NCF1 P14598 1/20 0.49
TERT O14746 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28276517 0.81 KDM4E (0.58) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL28012682 0.80 KDM4E (0.57) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL4216096 0.78 KDM4E (0.55) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL4221803 0.76 MEN1 (0.67) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL17420314 0.76 KDM4E (0.52) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL4221624 0.75 KDM4E (0.55) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL20784267 0.75 HTR3A (0.69) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL30103304 0.74 KDM4E (0.58) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL1978855 0.74 KDM4E (0.54) KDM4ENPC1RAB9ASMN1; SMN2GAA
SCHEMBL521324 0.73 MAPT (0.58) KDM4EGAAKMT2AMEN1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022271676-A1 INDOLE-SUBSTITUTED QUINOLINES AND THEIR COMBINATION WITH PLK1 INHIBITORS FOR THE TREATMENT OF CANCER UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2022-12-29 WO disclosed